Nitroso-Escitalopram Impurity 2 - Request Quote
Nitroso-Escitalopram Impurity 2
| SZ CAT No: | SZ-E002053 |
| CAS No | NA |
| Mol.F. | C19H19N3O2 |
| Mol.Wt. | 321.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nitroso-Escitalopram Impurity 2 is chemically N-(3-(5-Cyano-1-phenyl-1,3-dihydroisobenzofuran-1-yl)propyl)-N-methylnitrous amide. Nitroso-Escitalopram Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Nitroso-Escitalopram Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Escitalopram.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Nitroso-Escitalopram Impurity 2
Purchase Nitroso-Escitalopram Impurity 2
Nitroso-Escitalopram Impurity 2 suppliers
Nitroso-Escitalopram Impurity 2 manufacturers
Nitroso-Escitalopram Impurity 2 price
Order Nitroso-Escitalopram Impurity 2
Enquire Nitroso-Escitalopram Impurity 2
Nitroso-Escitalopram Impurity 2 cost
Nitroso-Escitalopram Impurity 2 Supplier
Nitroso-Escitalopram Impurity 2 Distributor
Nitroso-Escitalopram Impurity 2 for Method Validation
Escitalopram Reference Standard
Nitroso-Escitalopram Impurity 2 for ANDA Filing
Nitroso-Escitalopram Impurity 2 for Forced Degradation Studies
Nitroso-Escitalopram Impurity 2 Identification Standards
Nitroso-Escitalopram Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.